| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/12/2003 | WO2003074475A2 Substituted aryl ketones |
| 09/12/2003 | WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/12/2003 | WO2002056884A3 Treatment of malaria with farnesyl protein transferase inhibitors |
| 09/12/2003 | WO2002028855A3 Amorphous form of cell cycle inhibitor |
| 09/12/2003 | WO2002002488A9 Methods and compounds for modulating nuclear receptor coactivator binding |
| 09/12/2003 | CA2477717A1 Indolamid derivatives which possess glycogen phosphorylase inhibitory activity |
| 09/12/2003 | CA2477505A1 Diamino-pyrimidines and their use as angiogenesis inhibitors |
| 09/11/2003 | US20030171406 Medicinal compositions containing propenone derivatives |
| 09/11/2003 | US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/11/2003 | US20030171378 Indolinone derivatives |
| 09/11/2003 | US20030171377 Therapy for non-insulin dependent diabetes |
| 09/11/2003 | US20030171374 Viricides; prevent reproduction of human T-Cell lymphocyte virus |
| 09/11/2003 | US20030171368 Compounds which bind to integrin receptors; treatment of thromboembolic events, cardiovascular diseases, pulmonary diseases, tumors, gastrointestinal diseases |
| 09/11/2003 | US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases |
| 09/11/2003 | US20030171354 Indole derivatives |
| 09/11/2003 | US20030171309 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 09/11/2003 | US20030171218 Substituted 3-heteroaryl(amino- or oxy) pyrrolidin-2-ones of the formula (I), processes for preparing them, and their use as herbicides or as plant growth regulators. |
| 09/11/2003 | US20030170179 As contrast medium for fluorescence and transillumination diagnostics; drugs |
| 09/10/2003 | EP1342719A1 Benzodiazepine derivatives useful as CCK-Receptor Antagonists |
| 09/10/2003 | EP1341785A2 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 09/10/2003 | EP1341782A2 Inhibitors of p38 kinase |
| 09/10/2003 | EP1341772A2 Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests |
| 09/10/2003 | EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
| 09/10/2003 | EP1341769A2 Bacterial gyrase inhibitors and uses thereof |
| 09/10/2003 | EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS |
| 09/10/2003 | EP1341760A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors |
| 09/10/2003 | EP1341759A2 3-substituted oxindole beta 3 agonists |
| 09/10/2003 | EP1341540A2 Tyrosine kinase inhibitors |
| 09/10/2003 | EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| 09/10/2003 | EP1259522B1 Ligand and complex for catalytically bleaching a substrate |
| 09/10/2003 | EP0991650B1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
| 09/10/2003 | EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 09/10/2003 | CN1441800A Beta 3 adrenergic agonists |
| 09/10/2003 | CN1441788A Novel arylethene-sulfonamides compounds |
| 09/10/2003 | CN1441787A Modulators of TNF-alpha signaling |
| 09/10/2003 | CN1441779A Proline derivatives and use thereof as drugs |
| 09/10/2003 | CN1441679A Compositions containing therapentically active components having enhanced solubility |
| 09/09/2003 | US6617347 Selective β3 adrenergic agonists |
| 09/09/2003 | US6617332 Cyclic amidinourea derivatives |
| 09/09/2003 | US6617324 Substituted pyrazoles as p38 kinase inhibitors |
| 09/09/2003 | US6617282 Useful as herbicides, defoliants and desiccants. |
| 09/09/2003 | CA2228655C Preparation of triazoles by organometallic addition to ketones |
| 09/04/2003 | WO2003072572A1 Beta3-adrenergic receptor agonists |
| 09/04/2003 | WO2003072570A1 Antidiabetic agents |
| 09/04/2003 | WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 09/04/2003 | WO2003072551A1 Uracil-thioether |
| 09/04/2003 | WO2003072541A2 Chemical compounds |
| 09/04/2003 | WO2003072124A1 Induction method for cell differentiation |
| 09/04/2003 | WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones |
| 09/04/2003 | WO2003072100A1 Peroxisome proliferator activated receptor modulators |
| 09/04/2003 | WO2003072099A1 Peroxisome proliferator activated receptor modulators |
| 09/04/2003 | WO2003072056A2 Intranasal administration of mc4-r agonists |
| 09/04/2003 | WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 09/04/2003 | WO2003037891A8 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| 09/04/2003 | WO2002003977A3 Combinations of statins, estrogenic agents and optionally estrogens |
| 09/04/2003 | US20030166704 Hydrolysis of (R)-5-(2-benzenesulphonylethyl)-3-N-methylpyrrolidin-2-ylmethyl)-1-acet o-indole using potassium carbonate in methanol/water to form eletriptan or hydrobromide salt |
| 09/04/2003 | US20030166691 Phenylalanine derivatives |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer |
| 09/04/2003 | US20030166658 Condensing a heterocyclic ketone or aldehyde with a 2-(NH2-NH-)benzimidazole, -oxazole or -thiazole; ribonucleotide reductase inhibitors; anticarcinogenic and -tumor agents; also useful against multidrug resistant cells |
| 09/04/2003 | US20030166649 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | US20030166639 Dihydro-benzo[b][1,4]diazepin-2-one derivatives |
| 09/04/2003 | US20030166638 Technical field |
| 09/04/2003 | US20030166633 Pyridinylimidazoles |
| 09/04/2003 | US20030166616 A tachykinin antagonist for used as antiinflammatory agent, antiallergic agent, analgesic, antiemetics, treating irritable colon syndrome, skin disorders |
| 09/04/2003 | US20030165640 Filters for electronic display device |
| 09/04/2003 | CA2477287A1 Uracil-thioether |
| 09/04/2003 | CA2477008A1 Substituted pyrimidinones and pyrimidinthiones |
| 09/04/2003 | CA2476316A1 Beta3-adrenergic receptor agonists |
| 09/03/2003 | EP1340744A2 Hiv protease inhibitors |
| 09/03/2003 | EP1340500A1 Antidiabetic agents |
| 09/03/2003 | EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 09/03/2003 | EP1339708A2 Indole-type inhibitors of p38 kinase |
| 09/03/2003 | EP1339707A2 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
| 09/03/2003 | EP1339699A1 Substituted amidoalkyl uracils and the use thereof |
| 09/03/2003 | EP1339693A1 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres |
| 09/03/2003 | EP1339692A1 Novel compounds for use as hiv protease inhibitors |
| 09/03/2003 | EP1339678A2 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 09/03/2003 | EP1214300B1 Rate-controlled particles |
| 09/03/2003 | EP1152001B1 Squarylium compound and optical recording medium containing the same |
| 09/03/2003 | EP1113822B1 Near infrared fluorescent contrast agent and fluorescence imaging |
| 09/03/2003 | EP1077947B1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments |
| 09/03/2003 | EP1051144B1 Use of heterocyclic quaternary polyammonium polymers as protective agent for keratin fibres and cosmetic compositions |
| 09/03/2003 | EP0945445B1 1,5-benzodiazepine derivatives |
| 09/03/2003 | EP0612318B1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 09/03/2003 | CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/03/2003 | CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders |
| 09/03/2003 | CN1440393A Cyclic compounds |
| 09/03/2003 | CN1440391A Propane-1,3-dione derivatives |
| 09/03/2003 | CN1120159C Intermediate for preparing 1,4-disubstituted tetraazole-quinolinone |
| 09/03/2003 | CN1119988C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition |
| 09/02/2003 | US6613888 Azo dyes, process for making the same, ink-jet printing ink, ink-jet recording method |
| 09/02/2003 | US6613789 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 09/02/2003 | US6613776 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease |
| 09/02/2003 | US6613773 Pyrimidinyloxyphenyl-3-alkoxypropenoates derivatives |
| 09/02/2003 | US6613772 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 09/02/2003 | US6613760 Indole derivatives and their use as MCP-1 receptor antagonists |
| 09/02/2003 | US6613718 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them |
| 09/02/2003 | CA2216796C Quinazoline derivatives |